Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Tappenden, P. orcid.org/0000-0001-6612-2332, Carroll, C. orcid.org/0000-0002-6361-6182, Stevens, J. orcid.org/0000-0002-9867-7209 et al. (5 more authors) (2019) Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37 (1). pp. 7-18. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Springer Verlag. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy. The final publication is available at Springer via https://doi.org/10.1007/s40273-018-0680-z.
Dates:
  • Published (online): 27 June 2018
  • Published: 24 January 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 23 Jul 2018 09:59
Last Modified: 10 Aug 2020 13:11
Status: Published
Publisher: Springer
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-018-0680-z
Related URLs:

Share / Export

Statistics